Try our beta test site
IMPORTANT: Listing of a study on this site does not reflect endorsement by the National Institutes of Health. Talk with a trusted healthcare professional before volunteering for a study. Read more...

A Woman Suffered From Leukocytopenia and Widespread Migration After Polyacrylamide Hydrogel (PAAG) Injection in Epicranial Aponeurosis

This study has been completed.
Information provided by (Responsible Party):
Duo Zhang, First Hospital of Jilin University Identifier:
First received: January 24, 2012
Last updated: January 25, 2012
Last verified: January 2012
Polyacrylamide hydrogel (PAAG) has been used as an injectable filler for soft tissue augmentation in different parts of the body , such as face, breast , or even penis for more than a decade . However, there are never reports about the application of a large amount of PAAG in epicranial aponeurosis to change the contour of the upper cranium accompanied with leukocytopenia. This fancy application turned out to be a disaster for the women who suffered from leukocytopenia , widespread migration of PAAG, recurrent swelling of the affected tissues and temporal pain changing with the temperature and the facial expression .


Study Type: Observational
Study Design: Observational Model: Case-Only
Time Perspective: Retrospective

Further study details as provided by Duo Zhang, First Hospital of Jilin University:

Enrollment: 1
Study Start Date: October 2011

Ages Eligible for Study:   50 Years to 50 Years   (Adult)
Sexes Eligible for Study:   Female
Accepts Healthy Volunteers:   No
Sampling Method:   Probability Sample
Study Population
A 50-year-old lady had PAAG injected into her bilateral temporal epicranial aponeurosis for augmentation

Inclusion Criteria:

  • PAAG injected into bilateral temporal epicranial aponeurosis

Exclusion Criteria:

  • PAAG injected into other parts of the body
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

No Contacts or Locations Provided
  More Information

Responsible Party: Duo Zhang, professor, First Hospital of Jilin University Identifier: NCT01519362     History of Changes
Other Study ID Numbers: zhangduo
Study First Received: January 24, 2012
Last Updated: January 25, 2012

Keywords provided by Duo Zhang, First Hospital of Jilin University:
Polyacrylamide hydrogel
epicranial aponeurosis
PAAG injection processed this record on May 25, 2017